[
  {
    "title": "Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk",
    "published": 1713197290,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "Jim Cramer is Recommending These 10 Stocks in April",
    "published": 1713192174,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Eli Lilly",
    "published": 1713181440,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "Nvidia is the No. 1 S&P 500 growth stock in this screen. See which other companies joined or left the list.",
    "published": 1713181140,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), McKesson (MCK)",
    "published": 1713180060,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm",
    "published": 1713175200,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead",
    "published": 1713174360,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA), PolyPid (PYPD) and Eli Lilly & Co (LLY)",
    "published": 1713151260,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "BTIG Research Predicts Over 118% Rally for These 3 Stocks",
    "published": 1713144300,
    "posting_price": 755.16353769,
    "close_price": 745.92358398,
    "percent_change": -1.2235699
  },
  {
    "title": "Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down",
    "published": 1713070860,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "Jim Cramer\u2019s 10 Favorite Healthcare Stock Picks in 2024",
    "published": 1713025104,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "3 Magnificent Stocks That Could Double or More by 2030",
    "published": 1713012420,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?",
    "published": 1712995200,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says",
    "published": 1712952411,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Shark Tank's Mark Cuban speaks out on weight-loss drugs",
    "published": 1712948547,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock",
    "published": 1712926816,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating",
    "published": 1712924640,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March",
    "published": 1712924520,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "LLY, NVO: Obesity Drugs May Help with Parkinson\u2019s",
    "published": 1712922840,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "European regulator concludes no suicide link to obesity drugs",
    "published": 1712922300,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "GLP-1s benefit Parkinson\u2019s: Barclays sees implications across biopharma",
    "published": 1712919780,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding Pharmacy",
    "published": 1712919660,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says",
    "published": 1712915040,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Ozempic, similar weight-loss drugs don\u2019t increase suicide risk: EU regulator",
    "published": 1712914620,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Leerink sees 'marginal' Q1 downside for Lilly amid supply constraints",
    "published": 1712912160,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Obesity-drug power couple Novo Nordisk and Eli Lilly still have room to run, analysts say",
    "published": 1712909640,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Popular weight-loss drug doesn\u2019t increase suicide risk, EU regulator says",
    "published": 1712902560,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "No link between weight loss drugs and suicidal thoughts, EU regulator concludes",
    "published": 1712902140,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "7 A-Rated Aggressive Biotech Stocks to Bet On in 2024",
    "published": 1712900640,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027",
    "published": 1712899740,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Roche, Eli Lilly gain FDA breakthrough device tag for Alzheimer's blood test",
    "published": 1712813160,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Drugmakers look to alternative suppliers after draft U.S. legislation, FT says",
    "published": 1712812980,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Roche announces U.S. FDA granted BDD to its Elecsys pTau217 assay",
    "published": 1712812620,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024",
    "published": 1712806380,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next Milestone",
    "published": 1712804220,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Blood test by Roche and Eli gets FDA breakthrough device designation",
    "published": 1712802840,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to Know",
    "published": 1712785519,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild",
    "published": 1712778060,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "Insiders are Piling into These 10 Healthcare Stocks in 2024",
    "published": 1712777442,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?",
    "published": 1712755620,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "ClearBridge Appreciation Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712753700,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "Eli Lilly & Co: Strong Buy Rating on Robust \u2018Diabesity\u2019 Portfolio and Key Product Outperformance",
    "published": 1712724420,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "published": 1712720100,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies",
    "published": 1712716080,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "Top 10 best performing S&P 500 health care stocks of 2024",
    "published": 1712714220,
    "posting_price": 746.430398,
    "close_price": 757.0612793,
    "percent_change": 1.42422942
  },
  {
    "title": "10 Health Care Stocks With Whale Alerts In Today's Session",
    "published": 1712666400,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Eli Lilly launches construction of $2.5B plant to meet obesity drug demand",
    "published": 1712664720,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Cantor starts Structure at overweight, sees positive data for GLP-1 drug",
    "published": 1712662980,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "11 Best Biotech ETFs To Buy",
    "published": 1712662637,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Novo Nordisk: The Moat Won't Last Forever",
    "published": 1712662210,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up",
    "published": 1712660520,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "3 High-Growth Biotech Stocks Investors Shouldn\u2019t Sleep On in April",
    "published": 1712660400,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.",
    "published": 1712659500,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
    "published": 1712658900,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Jim Cramer Stands By Nvidia And Eli Lilly Despite Market Dips, Says 'Terrific Time To Take Some Profits'",
    "published": 1712655420,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Madrigal announces US launch of NASH/MASH drug Rezdiffra",
    "published": 1712653680,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Eli Lilly and Co's Options: A Look at What the Big Money is Thinking",
    "published": 1712652420,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Amphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of Opportunity",
    "published": 1712646540,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth",
    "published": 1712641773,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "MarketMasterAI\u2019s Top 500 Stocks: April 2024",
    "published": 1712633160,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Cabot Wealth\u2019s Top Ten list of stocks",
    "published": 1712627460,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Cabot\u2019s Top Ten list of stocks",
    "published": 1712625000,
    "posting_price": 772.62014352,
    "close_price": 752.35180664,
    "percent_change": -2.62332494
  },
  {
    "title": "Weight-loss drug shortage result of 'unprecedented demand'",
    "published": 1712612123,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Healthcare ETFs for the Weight-Loss Drug Boom & Beyond",
    "published": 1712604840,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "2 Growth Stocks to Buy Hand Over Fist in April",
    "published": 1712579400,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Zacks Market Edge Highlights: VICI Properties, KeyCorp, Meta Platforms, ExxonMobil and Eli Lilly",
    "published": 1712578200,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Trial shows Wegovy can ease heart failure symptoms",
    "published": 1712578140,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "ProfoundBio Discovers The Joys Of Having A Wealthy Owner",
    "published": 1712573460,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "This 1 Number May Ensure Eli Lilly's Dominance in the Weight Loss Drug Market",
    "published": 1712572200,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.",
    "published": 1712570100,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Lilly - Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance on risk of heart failure hospitalization and death in adults following a heart attack",
    "published": 1712561231,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Ionis Pharmaceuticals (IONS) and Medtronic (MDT)",
    "published": 1712551860,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Eli Lilly research costs rise but Jardiance trial disappoints",
    "published": 1712551800,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "EMA to discuss possible link between GLP-1s, suicidal thoughts: report",
    "published": 1712542500,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Could This New Development Soon Buoy Eli Lilly and Novo Nordisk Stock?",
    "published": 1712488500,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "The biggest S&P stocks have to do the heavy earnings lifting (again) - Goldman",
    "published": 1712484600,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "10 Best Weight Loss Drug Stocks to Buy Now",
    "published": 1712450873,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Jim Cramer is Bearish On These 10 Stocks in April",
    "published": 1712413222,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock",
    "published": 1712406600,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Is it Too Late to Buy Viking Therapeutics Stock?",
    "published": 1712403900,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Eli Lilly and : Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance\u00ae (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack",
    "published": 1712397246,
    "posting_price": 779.95254228,
    "close_price": 772.2723999,
    "percent_change": -0.98469355
  },
  {
    "title": "Eli Lilly and : Q1 Earnings 2024 Estimated Acquired IPR&D And Development Milestone Charges",
    "published": 1712334262,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "BME: Trading At A Historical Discount To NAV",
    "published": 1712317631,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "Viking Therapeutics Stock (NASDAQ:VKTX): Analysts Stay Bullish on 2024\u2019s Top Mid-Cap",
    "published": 1712317260,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds",
    "published": 1712316540,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Pfizer (PFE), Eli Lilly & Co (LLY)",
    "published": 1712316060,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment",
    "published": 1712309640,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "How a Biden-Trump rematch can keep healthcare ETFs afloat this election year",
    "published": 1712294760,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "Lilly to record $111M pre-tax IPR&D charges in Q1",
    "published": 1712293380,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "Eli Lilly sees Q1 pre-tax IPR&D charges of roughly $111M",
    "published": 1712287860,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "Traders Rethink Interest Rate Cuts, Labor Market Heats Up, Oil Prices Quietly Reach 6-Month High: This Week In The Markets",
    "published": 1712287560,
    "posting_price": 760.52874576,
    "close_price": 779.14782715,
    "percent_change": 2.44817589
  },
  {
    "title": "How to Create a Stock Portfolio that Pays $100 a Month",
    "published": 1712264700,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "3 Growth Stocks with Even Greater Potential Than the Magnificent 7",
    "published": 1712237580,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed",
    "published": 1712237410,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "10 Health Care Stocks Whale Activity In Today's Session",
    "published": 1712234280,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Baird puts Inspire on top idea list, sees limited impact by GLP-1s",
    "published": 1712233080,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?",
    "published": 1712220900,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Spring 2024 Snapshot Of The S&P 500's Market Cap",
    "published": 1712217900,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Eli Lilly & Co (LLY), UnitedHealth (UNH)",
    "published": 1712212860,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "7 A-Rated Stocks to Buy in April",
    "published": 1712210400,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.",
    "published": 1712206800,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?",
    "published": 1712196187,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Erste Group Upgrades Eli Lilly and (LLY)",
    "published": 1712178550,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Why Eli Lilly Stock Topped the Market Today",
    "published": 1712176262,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Verve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls",
    "published": 1712166000,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says",
    "published": 1712156728,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "UPDATE 2-Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says",
    "published": 1712156586,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Novo Nordisk's Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China",
    "published": 1712148060,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Dow Jones Futures: Market Slides But Holds Key Levels; Tesla Skids As Meta Eyes Buy Point",
    "published": 1712091226,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Verve Therapeutics Stock Remains A Hold After VERVE-101 Enrollment Pause",
    "published": 1712145465,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "What You Missed On Wall Street This Morning",
    "published": 1712143200,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Zepbound shortage: Eli Lilly's weight-loss drug in limited availability through April-end",
    "published": 1712142420,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Some doses of Lilly's Zepbound in short supply through April-end, US FDA says",
    "published": 1712142186,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Some doses of Lilly's Zepbound in limited availability, US FDA says",
    "published": 1712141117,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Unpacking the Latest Options Trading Trends in Eli Lilly and Co",
    "published": 1712138820,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Lilly weight loss drug on limited supply through April, FDA says",
    "published": 1712137980,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "FDA says Eli Lilly's Zepbound at limited availability through April",
    "published": 1712137740,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Why Nvidia Could Become The Largest Company, But Not For Long",
    "published": 1712136629,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Early notable gainers among liquid option names on April 3rd",
    "published": 1712134560,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Erste Group gets more bullish on Eli Lilly, upgrades shares",
    "published": 1712127300,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Novo\u2019s Ozempic to face copycats as Chinese firm seeks biosimilar nod",
    "published": 1712124180,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Glaukos (GKOS) and Omnicell (OMCL)",
    "published": 1712119260,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "What You Missed On Wall Street On Wednesday",
    "published": 1712114880,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "The 3 Best Healthcare Stocks to Buy in April 2024",
    "published": 1712114100,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy",
    "published": 1712113800,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Noteworthy Wednesday Option Activity: LLY, RH, IBM",
    "published": 1712111640,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras",
    "published": 1712111100,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note",
    "published": 1712094318,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Stocks Bend As Yields Rise; Meta Platforms, Uber, Eli Lilly In Focus",
    "published": 1712090144,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Some doses of Lilly's Mounjaro in tight supply through April, US FDA says",
    "published": 1712074927,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "UPDATE 1-Some doses of Lilly's Mounjaro in tight supply through April, US FDA says",
    "published": 1712074665,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "FDA website shows limited availability of some doses of Lilly's Mounjaro through April",
    "published": 1712070327,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly\u2019s Ozempic Competitors Face Risks. Why the Stock Has More Upside.",
    "published": 1712062440,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action",
    "published": 1712058354,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts",
    "published": 1712056740,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Outperforming ETF manager names a potential \u201850-bagger\u2019 in the stock market",
    "published": 1712055840,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly Stock Navigates Weight-Loss Drug Competition With Technical Resilience",
    "published": 1712054700,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "The Zacks Analyst Blog Highlights Apple, NVIDIA, Eli Lilly, American Tower and McKesson",
    "published": 1712050620,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Is It Too Late to Buy Eli Lilly Stock?",
    "published": 1712049000,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Verve drops after pausing trial enrollments for lead asset",
    "published": 1712040720,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Verve drops after pausing enrollments in trial for lead asset",
    "published": 1712039820,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Viking Therapeutics: Future Weight Loss Heavyweight?",
    "published": 1712037671,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Buy Amazon Stock Now for Continued Growth and Diversification",
    "published": 1712034420,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly price target raised by $220 at Citi, here's why",
    "published": 1712032500,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly Poised for Market Dominance Amid Positive orforglipron Trial Results and Legislative Tailwinds",
    "published": 1712030880,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "5 Healthcare Stocks to Buy for 2024",
    "published": 1712028660,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Citigroup Pounds the Table on Eli Lilly Stock",
    "published": 1712023860,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race",
    "published": 1712022900,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand",
    "published": 1712022180,
    "posting_price": 750.19581531,
    "close_price": 759.02844238,
    "percent_change": 1.17737621
  },
  {
    "title": "These 3 Companies Recently Lifted Guidance",
    "published": 1714513860,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "REFILE-CORRECTED-US STOCKS-Wall Street stocks fall as markets weigh strong wage data, Fed meeting",
    "published": 1714511661,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "US STOCKS-Wall Street ends lower as markets weigh strong wage data, Fed meeting",
    "published": 1714509596,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Stocks End April On Sour Note, Dow Loses 570 Points",
    "published": 1714509489,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "US Equity Markets Close Down Tuesday After Higher Wage Data",
    "published": 1714507543,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "US STOCKS-Wall Street stocks fall as markets weigh strong wage data, Fed meeting",
    "published": 1714507243,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Sector Update: Health Care Stocks Mixed Late Afternoon",
    "published": 1714507105,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Stocks At Day's Lows As Dow Loses 400 Points; These Stocks Flash Sell Signals",
    "published": 1714504929,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly (LLY) Q1 2024 Earnings Call Transcript",
    "published": 1714501816,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Stocks Keep Sinking, With Dow Losing 300 Points; IBD 50 Stock Hubbell Plunges",
    "published": 1714500009,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Taxpayer to fork out \u00a385bn to cover Bank of England losses",
    "published": 1714499961,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024",
    "published": 1714497810,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Potential for Weight-Loss Drugs Boosts Eli Lilly",
    "published": 1714496660,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Lilly Soars as Forecast Boost Shows Weight-Loss Drugs\u2019 Power",
    "published": 1714494390,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views",
    "published": 1714494077,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "NEW YORK MARKET CLOSE: Dow hit by new inflationary scare ahead of Fed",
    "published": 1714493880,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings",
    "published": 1714492780,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates",
    "published": 1714492200,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised",
    "published": 1714491900,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast",
    "published": 1714491667,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "US STOCKS-Wall St falls on hot labor costs data, caution before Fed verdict",
    "published": 1714491500,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Why Eli Lilly Stock Is Jumping Today",
    "published": 1714490760,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly stock jumps on weight-loss drug sales forecast",
    "published": 1714489595,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Earnings Data Deluge",
    "published": 1714488480,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly's GLP-1 demand drives up stock price post Q1 results",
    "published": 1714488044,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Trending : Eli Lilly Reports Strong Sales of Weight-Loss, Diabetes Drugs",
    "published": 1714487795,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "US STOCKS-Wall St falls in lead up to Fed verdict after hot labor costs data",
    "published": 1714486889,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Wall Street Lunch: Reefer Gladness",
    "published": 1714486800,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Pre-Markets Sell on Last Trading Day of April",
    "published": 1714486620,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly and Company (LLY) Q1 2024 Earnings Call Transcript",
    "published": 1714483629,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "10 Health Care Stocks With Whale Alerts In Today's Session",
    "published": 1714480860,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Stocks Dive On Fears Of Hawkish Fed; Treasury Yields Rise, Bitcoin Tumbles To $60,000: What's Driving Markets Tuesday?",
    "published": 1714480560,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session",
    "published": 1714480200,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024",
    "published": 1714479720,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly and Company 2024 Q1 - Results - Earnings Call Presentation",
    "published": 1714478544,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "What You Missed On Wall Street This Morning",
    "published": 1714474980,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight",
    "published": 1714474920,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "FOMC Meeting Samsung Over Takes Apple, AI Demand Indication Ahead From AMD, Amazon And Super Micro",
    "published": 1714472700,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday",
    "published": 1714470960,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "LLY Stock Earnings: Eli Lilly Beats EPS, Misses Revenue for Q1 2024",
    "published": 1714470900,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Biggest stock movers today: LLY, NXPI, MSTR, ST, and more",
    "published": 1714470300,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "FTC expands patent listing challenges for drugs",
    "published": 1714468440,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues",
    "published": 1714467976,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "LLY Earnings: Eli Lilly Gains on Strong Q1 Earnings Beat",
    "published": 1714467600,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Early notable gainers among liquid option names on April 30th",
    "published": 1714467300,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Unusually active option classes on open April 30th",
    "published": 1714466400,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Qiagen (QGEN), Eli Lilly & Co (LLY)",
    "published": 1714465980,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Bank of America Securities Keeps Their Buy Rating on Eli Lilly & Co (LLY)",
    "published": 1714465800,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "TOP NEWS: Eli Lilly lifts outlook, ramps up production to meet demand",
    "published": 1714465560,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "5 stocks to watch on Tuesday: KO, MCD, AMZN and more",
    "published": 1714465500,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Fly Intel: Pre-market Movers",
    "published": 1714465380,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly: target ranges raised for 2024",
    "published": 1714463248,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Morning Brew: Tech Giants Lead Market Movements Amidst Earnings Season",
    "published": 1714462260,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly and : Q1 Earnings 2024 Press Release",
    "published": 1714460331,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly and : Q1 Earnings 2024 Earnings Presentation",
    "published": 1714460330,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Lilly: Q1 Earnings Snapshot",
    "published": 1714460050,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly beats profit estimates on diabetes and weight-loss drug strength",
    "published": 1714459609,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum",
    "published": 1714459572,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly\u2019s stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro, Zepbound",
    "published": 1714459440,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly raises guidance on weight loss momentum",
    "published": 1714458900,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly and Co (LLY) Surpasses Q1 Earnings Estimates and Raises Full-Year Guidance",
    "published": 1714458780,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly in charts: Mounjaro, Zepbound, Verzenio, and Jardiance drive revenue growth in Q1; Trulicity declines 26%",
    "published": 1714457160,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly raises FY24 adjusted EPS view to $13.50-$14.00 from $12.20-$12.70",
    "published": 1714456920,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Wall Street On Edge Ahead Of Fed Decision, Spotlight Falls On Amazon And AMD Earnings: Analyst Says Stocks Survive 'Fragility Test' As April Ends",
    "published": 1714456920,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly reports Q1 EPS $2.58, consensus $2.46",
    "published": 1714456800,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M",
    "published": 1714456140,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Stock market today: An ugly April for Wall Street is closing with some more losses",
    "published": 1714442160,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Markets Up On Tesla, Q1 Earnings; Q1 Beats After The Bell",
    "published": 1714439160,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "GLOBAL BRIEFING: HSBC CEO to retire; first-quarter profit edges down",
    "published": 1714438080,
    "posting_price": 769.99720142,
    "close_price": 776.05780029,
    "percent_change": 0.78709362
  },
  {
    "title": "Why these analysts are bullish on healthcare stocks",
    "published": 1714424693,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "All Eyes Are on Zepbound Sales as Lilly Reports Earnings",
    "published": 1714422900,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk",
    "published": 1714419332,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "UPDATE 1-One dose of Novo Nordisk's Wegovy back in supply, FDA website shows",
    "published": 1714407142,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report",
    "published": 1714401134,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Here's How Much Stock Eli Lilly Repurchased in 2023",
    "published": 1714400100,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Novo Nordisk: Growth Is Still A Better Choice",
    "published": 1714399203,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week",
    "published": 1714395360,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Notable companies reporting before tomorrow's open",
    "published": 1714394760,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Eli Lilly Q1 Earnings Preview: Weight loss therapies to drive quarterly growth",
    "published": 1714392900,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Notable earnings before Tuesday's open",
    "published": 1714386060,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Global company events calendar",
    "published": 1714382940,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Pipeline Moves: Investigator-led trial of Lilly\u2019s merestinib in solid tumours terminated",
    "published": 1714377669,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Options Volatility and Implied Earnings Moves This Week, April 29 \u2013 May 02, 2024",
    "published": 1714370460,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Eli Lilly & Co (LLY) Gets a Buy from Barclays",
    "published": 1714366020,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Dow Jones Futures Rise: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom",
    "published": 1714350106,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Eli Lilly Just Announced More Good News: Time to Buy?",
    "published": 1714324620,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "What do weight-loss drugs mean for the diet industry?",
    "published": 1714297020,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Wall Street Breakfast: The Week Ahead",
    "published": 1714288946,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Earnings week ahead: Amazon, Apple, Pfizer, AMD, Coca-Cola, Starbucks and more",
    "published": 1714287780,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Roche: Value Remains Despite Covid-19 Revenue Growth Loss",
    "published": 1714283098,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Forget Nvidia, These Unstoppable Stocks Are Better Buys",
    "published": 1714230600,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On",
    "published": 1714223700,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Goldman Sachs\u2019 Top 15 Stock Picks for 2024",
    "published": 1714222456,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "3 Dividend Stocks to Buy and Hold for the Next Decade",
    "published": 1714216500,
    "posting_price": 731.00057109,
    "close_price": 732.44122314,
    "percent_change": 0.19707947
  },
  {
    "title": "Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom",
    "published": 1714166446,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed",
    "published": 1714154455,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "IN BRIEF: Eli Lilly urges shareholders to reject Tutanota's offer",
    "published": 1714150140,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "Eli Lilly and : Lilly Recommends Shareholders Reject \u201cMini-Tender\u201d Offer by Tutanota LLC",
    "published": 1714149409,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks",
    "published": 1714143739,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "ClearBridge Global Growth Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1714133700,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy",
    "published": 1714132834,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "SPDR ETF Report For Friday, April 26",
    "published": 1714132020,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "AstraZeneca: Strong In A Weak Market",
    "published": 1714131236,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "LLY June 7th Options Begin Trading",
    "published": 1714126380,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'",
    "published": 1714124220,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "EOI: 9% Plus Income, Paid Monthly, And Solid Past Record",
    "published": 1714122000,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "Catalyst Watch: Apple earnings, Viking IPO, Chinese EV deliveries and Russell indices' Rank Day",
    "published": 1714097160,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "More than half of the S&P 500 names that reported results this week beat top and bottom line - Earnings Scorecard",
    "published": 1714093680,
    "posting_price": 718.80980159,
    "close_price": 728.77508545,
    "percent_change": 1.38635893
  },
  {
    "title": "These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)",
    "published": 1714067356,
    "posting_price": 720.31996157,
    "close_price": 720.1907959,
    "percent_change": -0.01793171
  },
  {
    "title": "20 Fastest Growing Health Tech Companies in the World",
    "published": 1714059264,
    "posting_price": 720.31996157,
    "close_price": 720.1907959,
    "percent_change": -0.01793171
  },
  {
    "title": "Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics",
    "published": 1714050926,
    "posting_price": 720.31996157,
    "close_price": 720.1907959,
    "percent_change": -0.01793171
  },
  {
    "title": "Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie",
    "published": 1714048380,
    "posting_price": 720.31996157,
    "close_price": 720.1907959,
    "percent_change": -0.01793171
  },
  {
    "title": "Dividend Legends: 3 Stocks With Over 100 Years of Payouts",
    "published": 1714043520,
    "posting_price": 720.31996157,
    "close_price": 720.1907959,
    "percent_change": -0.01793171
  },
  {
    "title": "What's Driving AstraZeneca PLC's Surprising 14% Stock Rally?",
    "published": 1714040280,
    "posting_price": 720.31996157,
    "close_price": 720.1907959,
    "percent_change": -0.01793171
  },
  {
    "title": "Don\u2019t Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List",
    "published": 1714021860,
    "posting_price": 720.31996157,
    "close_price": 720.1907959,
    "percent_change": -0.01793171
  },
  {
    "title": "Eli Lilly & Co. stock outperforms competitors despite losses on the day",
    "published": 1714016400,
    "posting_price": 720.31996157,
    "close_price": 720.1907959,
    "percent_change": -0.01793171
  },
  {
    "title": "Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?",
    "published": 1713974700,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "4 Large Drug Stocks to Hold on to Amid Industry Challenges",
    "published": 1713967740,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for",
    "published": 1713967314,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?",
    "published": 1713965100,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Madrigal: 2 Challenges To Overcome To Maintain NASH 'First Mover' Advantage",
    "published": 1713963750,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know",
    "published": 1713963614,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market",
    "published": 1713955200,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "LLY vs. JNJ: Which Big Pharma Stock Is Better?",
    "published": 1713954240,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Eaton Vance Worldwide Health Sciences Fund Bolsters Position in IDEXX Laboratories",
    "published": 1713952920,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Artisan International Fund Q1 2024 Commentary",
    "published": 1713952800,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "3.6M Medicare patients could qualify for Wegovy coverage: report",
    "published": 1713951000,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "14 Dividend Growth Stocks with Highest Growth Rates",
    "published": 1713942152,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains",
    "published": 1713937140,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "JGRO: Promising ETF In The Growth Category",
    "published": 1713935367,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Madison Sustainable Equity Fund Q1 2024 Investment Strategy Letter",
    "published": 1713933000,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Novo Nordisk comes under Senate probe over pricing of weight loss drugs",
    "published": 1713927420,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Novo Nordisk comes under Senate probe over pricing for weight loss drugs",
    "published": 1713926700,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses",
    "published": 1713923640,
    "posting_price": 747.78163151,
    "close_price": 727.47357178,
    "percent_change": -2.71577408
  },
  {
    "title": "Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth",
    "published": 1713880861,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "3 Potential Biopharma Buyout Targets",
    "published": 1713877968,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "Eli Lilly and Company (LLY) Rose due to Robust Q4 Sales",
    "published": 1713873618,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "REITs Q1 Earnings Begin On Solid Note",
    "published": 1713872040,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "Market Whales and Their Recent Bets on LLY Options",
    "published": 1713869280,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "TikTok to restrict weight loss drug promotion",
    "published": 1713868620,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "Baron Health Care Fund Q1 2024 Shareholder Letter",
    "published": 1713864600,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "3 Stocks With the Potential to Surpass Analyst Expectations for 2024",
    "published": 1713852120,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "PPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returns",
    "published": 1713846878,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "TikTok to restrict weight loss drug promotion (updated)",
    "published": 1713839220,
    "posting_price": 736.41539748,
    "close_price": 740.87640381,
    "percent_change": 0.60577309
  },
  {
    "title": "Eli Lilly (LLY) Advances But Underperforms Market: Key Facts",
    "published": 1713822319,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Lilly to buy injectable drug plant in manufacturing ramp-up",
    "published": 1713808200,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Eli Lilly to acquire manufacturing facility from Nexus Pharma",
    "published": 1713800457,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "10 Best Performing Biotech ETFs in 2024",
    "published": 1713798659,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Wall Street Lunch: Big Tech Bearishness?",
    "published": 1713792300,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "7 High-Flying Stocks That Are Majorly Overdue for a Pullback",
    "published": 1713789960,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans",
    "published": 1713787500,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade)",
    "published": 1713787200,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Eli Lilly: agreement to purchase a Nexus plant in the USA",
    "published": 1713784894,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Eli Lilly and : Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals",
    "published": 1713780851,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Eli Lilly buys injectable medicine manufacturing facility in Wisconsin",
    "published": 1713777840,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Novo Nordisk Remains The Better Buy After A Moderate Pullback",
    "published": 1713776400,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending",
    "published": 1713774360,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Top high growth investment ratio stocks from each sector - GS",
    "published": 1713756360,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Eli Lilly & Co (LLY)",
    "published": 1713754260,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma",
    "published": 1713749280,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Nvidia Down 10%, Time To Buy Tech",
    "published": 1713740115,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "11 Hot Growth Stocks To Buy Right Now",
    "published": 1713710984,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "13 new obesity drugs could hit the market by 2029 amid surging demand",
    "published": 1713683220,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Goldman picks top capex and R&D stocks",
    "published": 1713663840,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "10 Best Healthcare Stocks to Buy Under $20",
    "published": 1713618969,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential",
    "published": 1713616200,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "THQ: Collecting A High Yield From Increased Medical Spending",
    "published": 1713614580,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "3 Relatively Safe Growth Stocks You Can Buy and Hold",
    "published": 1713610080,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.",
    "published": 1713598260,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "SPDR ETF Report For Friday, April 19",
    "published": 1713581280,
    "posting_price": 725.02936796,
    "close_price": 726.60913086,
    "percent_change": 0.2178895
  },
  {
    "title": "Weight loss drugs and the many use cases in medical treatments",
    "published": 1713562377,
    "posting_price": 744.32399541,
    "close_price": 721.621521,
    "percent_change": -3.05007961
  },
  {
    "title": "Eli Lilly Shares Show Healthy Rise",
    "published": 1713541681,
    "posting_price": 744.32399541,
    "close_price": 721.621521,
    "percent_change": -3.05007961
  },
  {
    "title": "Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data",
    "published": 1713532500,
    "posting_price": 744.32399541,
    "close_price": 721.621521,
    "percent_change": -3.05007961
  },
  {
    "title": "Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now",
    "published": 1713508320,
    "posting_price": 744.32399541,
    "close_price": 721.621521,
    "percent_change": -3.05007961
  },
  {
    "title": "Influencers are talking up weight loss drugs, but omit side effects, WSJ says",
    "published": 1713503880,
    "posting_price": 744.32399541,
    "close_price": 721.621521,
    "percent_change": -3.05007961
  },
  {
    "title": "Hepion ends Phase 2 study for NASH drug due to cash restraints",
    "published": 1713499980,
    "posting_price": 744.32399541,
    "close_price": 721.621521,
    "percent_change": -3.05007961
  },
  {
    "title": "Intuitive Surgical (ISRG) Surpasses Q1 Earnings, Faces Supply Challenges",
    "published": 1713492900,
    "posting_price": 744.32399541,
    "close_price": 721.621521,
    "percent_change": -3.05007961
  },
  {
    "title": "13 Best Low Volatility Stocks to Buy According to Hedge Funds",
    "published": 1713472023,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "How The Weight-Loss Bonanza Prompted A ResMed Sell-Off \u2014 But Could Soon Drive Shares Higher",
    "published": 1713450787,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025",
    "published": 1713466252,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "India's Biocon developing its own version of Wegovy, clinical trial likely next year",
    "published": 1713457241,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Company News for Apr 18, 2024",
    "published": 1713444780,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies",
    "published": 1713444660,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "14 Best Large Cap Dividend Growth Stocks To Buy Now",
    "published": 1713442555,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years",
    "published": 1713432960,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.",
    "published": 1713432480,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years",
    "published": 1713431400,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), TG Therapeutics (TGTX)",
    "published": 1713429060,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "The Zacks Analyst Blog Highlights Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo",
    "published": 1713428400,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "UBS remains bullish on Inspire Medical after Lilly's OSA results",
    "published": 1713425100,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Analysts Conflicted on These Healthcare Names: Intra-Cellular Therapies (ITCI), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)",
    "published": 1713424860,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo",
    "published": 1713423600,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Inspire Medical Systems (INSP), Eli Lilly & Co (LLY)",
    "published": 1713421860,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB) and Eli Lilly & Co (LLY)",
    "published": 1713421260,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), US Physical Therapy (USPH)",
    "published": 1713416460,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Zoetis (ZTS) and TScan Therapeutics (TCRX)",
    "published": 1713414780,
    "posting_price": 744.58233702,
    "close_price": 741.13476562,
    "percent_change": -0.46302084
  },
  {
    "title": "Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank",
    "published": 1713394313,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Top Research Reports for Eli Lilly, Linde & Caterpillar",
    "published": 1713388200,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Stocks Fall After Fed Data; Nvidia Tests Key Level While Tesla's Musk Faces Shareholder Vote",
    "published": 1713385994,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Eli Lilly Pops After Weight-Loss Drug Succeeds In Sleep Apnea Test; ResMed Dives",
    "published": 1713358653,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Stocks Deepen Losses Ahead Of Fed Data; Tesla Falls As Musk Gets Shareholder Vote, While Chip Leader Plunges",
    "published": 1713370934,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Eli Lilly's weight loss drug could help sleep apnea patients",
    "published": 1713368522,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Eli Lilly's Famed Weight Loss Drug Zepbound Works As Sleep Apnea Treatment, Successful Late-Stage Studies Show",
    "published": 1713365995,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Eli Lilly\u2019s Zepbound Weight Loss Drug Works on Sleep Apnea, Too",
    "published": 1713363780,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "US STOCKS-Wall St gains from megacaps thrust; earnings, Fed comments on tap",
    "published": 1713362682,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Eli Lilly Stock Gains After Study Shows Weight-Loss Drug Combats Sleep Apnea",
    "published": 1713361408,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "UPDATE 2-Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says",
    "published": 1713361276,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Trending : Eli Lilly Weight-Loss Drug Works on Sleep Apnea",
    "published": 1713359656,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "US STOCKS-Wall St set for higher open on megacaps boost; earnings, Fed comments on tap",
    "published": 1713358649,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "United Airlines, Eli Lilly rise; JB Hunt, Travelers fall, Wednesday, 4/17/2024",
    "published": 1713358020,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Lilly obesity drug shows benefit in sleep disorder study, pointing to new use",
    "published": 1713355740,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Wall Street Lunch: Lilly In Limelight",
    "published": 1713353220,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Eli Lilly's Mounjaro, Zepbound to remain in shortage through end of Q2",
    "published": 1713352140,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Eli Lilly\u2019s Weight Loss Drug Shows Promising Results for Sleep Apnea",
    "published": 1713351360,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "Eli Lilly says weight-loss drug Zepbound proved effective as a treatment for sleep apnea",
    "published": 1713350700,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  },
  {
    "title": "UPDATE 4-Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials",
    "published": 1713349632,
    "posting_price": 754.29915864,
    "close_price": 745.92358398,
    "percent_change": -1.11037836
  }
]